title: Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
abstract: p27 (Kip1) plays regulatory roles in the cell cycle by inhibiting the activity of cyclin dependent kinases (CDKs). This immunohistochemical study is aimed at elucidating the expression of p27 in human pituitary and in various types of pituitary adenomas in order to clarify its role in the regulation of proliferation. Sixteen normal pituitary glands and 179 human pituitary adenomas were used for immunohistochemical studies. The tissues were fixed in 10% formalin and embedded in paraffin. Indirect peroxidase method was performed after heat-induced antigen retrieval using a monoclonal antibody against p27 protein. p27 protein was expressed in the nuclei of all 16 normal human pituitary glands. p27 protein was also expressed in 128 of 179 cases of pituitary adenomas (71.5%). A marked decrease of p27 expression was noted in ACTH-secreting adenomas, 8/20 (40.0%), compared with other types of pituitary adenomas--GH-secreting adenomas, 35/46 (76.1%); PRL-secreting adenomas, 22/33 (66.7%); TSH-secreting adenomas, 8/11 (72.7%); and nonfunctioning adenomas, 55/69 (79.7%). These results suggest that p27 may play some role in the regulation of proliferation in all types of pituitary adenomas. The lower levels of p27 in ACTH-secreting adenoma is of particular interest with respect to the intermediate lobe-derived pituitary tumor developed in p27 knockout mice.
authors.affiliation: Department of Neurosurgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Komatsubara
authors.forename: S
authors.initials: S
authors.lastname: Tahara
authors.forename: K
authors.initials: K
authors.lastname: Umeoka
authors.forename: N
authors.initials: N
authors.lastname: Sanno
authors.forename: A
authors.initials: A
authors.lastname: Teramoto
authors.forename: R Y
authors.initials: RY
authors.lastname: Osamura
mesh_terms: D000236:Adenoma / Q000737:chemistry* / Q000378:metabolism / Q000473:pathology; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D018797:Cell Cycle Proteins / Q000032:analysis*; D050760:Cyclin-Dependent Kinase Inhibitor p27; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D009361:Neoplasm Invasiveness; D010903:Pituitary Gland, Anterior / Q000737:chemistry* / Q000378:metabolism / Q000473:pathology; D010911:Pituitary Neoplasms / Q000737:chemistry* / Q000378:metabolism / Q000473:pathology; D015175:Prolactinoma / Q000737:chemistry; D013972:Thyrotropin / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000032:analysis*
chemical_list: D018797:Cell Cycle Proteins; D025521:Tumor Suppressor Proteins; D019382:Human Growth Hormone; D050760:Cyclin-Dependent Kinase Inhibitor p27; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin